Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.
Oncotarget
; 8(50): 87638-87646, 2017 Oct 20.
Article
in En
| MEDLINE
| ID: mdl-29152107
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncotarget
Year:
2017
Document type:
Article
Affiliation country:
Canada
Country of publication:
United States